GB0314260D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0314260D0
GB0314260D0 GBGB0314260.1A GB0314260A GB0314260D0 GB 0314260 D0 GB0314260 D0 GB 0314260D0 GB 0314260 A GB0314260 A GB 0314260A GB 0314260 D0 GB0314260 D0 GB 0314260D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0314260.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0314260.1A priority Critical patent/GB0314260D0/en
Publication of GB0314260D0 publication Critical patent/GB0314260D0/en
Priority to PCT/GB2004/002599 priority patent/WO2004113285A1/en
Priority to KR1020057024130A priority patent/KR20060010840A/ko
Priority to US10/561,161 priority patent/US7429675B2/en
Priority to EP04736920A priority patent/EP1638929A1/en
Priority to AU2004249487A priority patent/AU2004249487A1/en
Priority to JP2006516435A priority patent/JP2006527751A/ja
Priority to MXPA05013716A priority patent/MXPA05013716A/es
Priority to CA002529252A priority patent/CA2529252A1/en
Priority to BRPI0411450-7A priority patent/BRPI0411450A/pt
Priority to CNA2004800231458A priority patent/CN1835918A/zh
Priority to IL172376A priority patent/IL172376A0/en
Priority to ZA200509944A priority patent/ZA200509944B/en
Priority to NO20055883A priority patent/NO20055883L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896—Compounds having one or more Si-O-acyl linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GBGB0314260.1A 2003-06-19 2003-06-19 Therapeutic agents Ceased GB0314260D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0314260.1A GB0314260D0 (en) 2003-06-19 2003-06-19 Therapeutic agents
CNA2004800231458A CN1835918A (zh) 2003-06-19 2004-06-16 外消旋2－{[2－(4－羟基苯基)乙基]硫基}－3－[4－(2－{4－[(甲磺酰基)氧基]苯氧基}乙基)苯基]－丙酸的制备方法
JP2006516435A JP2006527751A (ja) 2003-06-19 2004-06-16 ラセミ体の２−｛［２−（４−ヒドロキシフェニル）エチル］チオ｝−３−［４−（２−｛４−［（メチルスルホニル）オキシ］フェノキシ｝エチル）フェニル］プロパン酸を製造するための方法
CA002529252A CA2529252A1 (en) 2003-06-19 2004-06-16 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
US10/561,161 US7429675B2 (en) 2003-06-19 2004-06-16 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
EP04736920A EP1638929A1 (en) 2003-06-19 2004-06-16 Process for the preparation of racemic 2- ¬2-(4-hydroxyphenyl)ethyl|-thio -3-¬4-(2- 4-¬(methylsulfonyl)oxy|phenoxy ethyl)phenyl|propanoic acid.
AU2004249487A AU2004249487A1 (en) 2003-06-19 2004-06-16 Process for the preparation of racemic 2-{(2-(4-hydroxyphenyl)ethyl)thio}-3-(4-(2-{4-((methylsulfonyl)oxy)phenoxy}ethyl)phenyl)-propanoic acid
PCT/GB2004/002599 WO2004113285A1 (en) 2003-06-19 2004-06-16 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
MXPA05013716A MXPA05013716A (es) 2003-06-19 2004-06-16 Procedimiento para la preparacion de acido 2-([2-(4 -hidroxifenil) etil]tio)-3 -[4-(2-(2- [metilsulfonil) oxi]fenoxi) etil)fenil] -propanoico racemico.
KR1020057024130A KR20060010840A (ko) 2003-06-19 2004-06-16 라세미2-[[2-(4-히드록시페닐)에틸]티오]-3-[4-(2-[4-[(메틸설포닐)옥시]페녹시]에틸)페닐]프로판산의 제조 방법
BRPI0411450-7A BRPI0411450A (pt) 2003-06-19 2004-06-16 processo para a preparação de um composto, e, composto
IL172376A IL172376A0 (en) 2003-06-19 2005-12-05 Process for the preparation of racemic 2{[2-(4- hydroxyphenyl)ethyl]thio}-3-[4-(2-{4- [(methylsulphonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
ZA200509944A ZA200509944B (en) 2003-06-19 2005-12-07 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
NO20055883A NO20055883L (no) 2003-06-19 2005-12-12 Fremgangsmate for fremstilling av racemisk 2-{[2-(4-hydroksfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]fenoksy}etyl)fenyl]-propansyre

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314260.1A GB0314260D0 (en) 2003-06-19 2003-06-19 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0314260D0 true GB0314260D0 (en) 2003-07-23

Family

ID=27636892

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0314260.1A Ceased GB0314260D0 (en) 2003-06-19 2003-06-19 Therapeutic agents

Country Status (14)

Country Link
US (1) US7429675B2 (enExample)
EP (1) EP1638929A1 (enExample)
JP (1) JP2006527751A (enExample)
KR (1) KR20060010840A (enExample)
CN (1) CN1835918A (enExample)
AU (1) AU2004249487A1 (enExample)
BR (1) BRPI0411450A (enExample)
CA (1) CA2529252A1 (enExample)
GB (1) GB0314260D0 (enExample)
IL (1) IL172376A0 (enExample)
MX (1) MXPA05013716A (enExample)
NO (1) NO20055883L (enExample)
WO (1) WO2004113285A1 (enExample)
ZA (1) ZA200509944B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
EP1517883B8 (en) 2002-06-20 2008-05-21 AstraZeneca AB Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
GB0314075D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0427524D0 (en) 2004-12-16 2005-01-19 Astrazeneca Ab Chemical process
KR101558005B1 (ko) * 2007-03-08 2015-10-06 알비레오 에이비 2-치환-3-페닐프로피온산 유도체 및 염증성 장 질환 치료에서의 그의 용도
FR2986804A1 (fr) * 2012-02-09 2013-08-16 Servier Lab Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193113B1 (en) * 1985-02-25 1992-01-22 Mitsubishi Gas Chemical Company, Inc. Process for optically isomerizing optically active alpha-amino acid amides and process for producing optically active alpha-amino acids
JPS61197530A (ja) * 1985-02-25 1986-09-01 Mitsubishi Gas Chem Co Inc ラセミ化法
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE0104333D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
EP1638929A1 (en) 2006-03-29
CN1835918A (zh) 2006-09-20
ZA200509944B (en) 2006-12-27
NO20055883L (no) 2006-01-09
BRPI0411450A (pt) 2006-07-18
MXPA05013716A (es) 2006-03-08
US20060167309A1 (en) 2006-07-27
KR20060010840A (ko) 2006-02-02
JP2006527751A (ja) 2006-12-07
WO2004113285A1 (en) 2004-12-29
IL172376A0 (en) 2009-02-11
AU2004249487A1 (en) 2004-12-29
CA2529252A1 (en) 2004-12-29
US7429675B2 (en) 2008-09-30

Similar Documents

Publication Publication Date Title
GB0303910D0 (en) Therapeutic agents
GB0308318D0 (en) Therapeutic agents
GB0314079D0 (en) Therapeutic agents
GB0314057D0 (en) Therapeutic agents
GB0313250D0 (en) Therapeutic agents
GB0314261D0 (en) Therapeutic agents
GB0316237D0 (en) Therapeutic agents
GB0314049D0 (en) Therapeutic agents
GB0316232D0 (en) Therapeutic agents
GB0314129D0 (en) Therapeutic agents
GB0311859D0 (en) Therapeutic agents
GB0311201D0 (en) Therapeutic agents
GB0301350D0 (en) Therapeutic agents
GB0314136D0 (en) Therapeutic agents
GB0314130D0 (en) Therapeutic agents
GB0314260D0 (en) Therapeutic agents
GB0304524D0 (en) Therapeutic agents
GB0314075D0 (en) Therapeutic agents
GB0314134D0 (en) Therapeutic agents
GB0314131D0 (en) Therapeutic agents
GB0314078D0 (en) Therapeutic agents
GB0305283D0 (en) Therapeutic agents
GB0305281D0 (en) Therapeutic agents
GB0313646D0 (en) Therapeutic agents
GB0308761D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)